Trials / Sponsors / Precision Life Sciences Group
Precision Life Sciences Group
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma Glioblastoma Multiforme | Phase 3 | 2024-12-01 |
| Completed | A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma Glioblastoma Multiforme | Phase 1 | 2013-12-01 |
| Completed | A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM) Glioblastoma Multiforme | Phase 2 | 2011-01-01 |